Navigation Links
Westaim terminates reorganization agreement and cancels shareholders' meeting
Date:11/4/2008

CALGARY, Nov. 4 /PRNewswire-FirstCall/ - The Westaim Corporation announced today that its reorganization agreement with several western Canadian construction services companies has been terminated.

Under the terms of the proposed reorganization agreement dated on October 3, 2008, subscription agreements for a private placement of common shares for gross proceeds of $15 million were required to be signed and delivered within 14 days of the mailing of the information circular for Westaim's special meeting of shareholders. Due to the current volatile state of the financial markets and the general state of the investment climate, sufficient subscribers for the private placement could not be found.

As a consequence of terminating the reorganization agreement, Westaim has cancelled the shareholders' meeting called for November 21, 2008.

"Westaim will continue its review of strategic alternatives in light of this development," said Drew Fitch, President & CEO, The Westaim Corporation. "The board of directors will examine all possible options for the longer-term structure of the company moving forward and remain committed to realizing maximum value for shareholders."

The Westaim Corporation's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.


'/>"/>
SOURCE Westaim Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Westaim to deregister its common stock in the United States
2. Westaim announces sale of iFire Technology Ltd. assets
3. Westaim announces 2008 second quarter results
4. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Second Quarter Results
5. Westaim announces 2008 first quarter results
6. Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
7. Westaim announces 2007 year-end results
8. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
9. Westaim reduces ABCP exposure
10. Westaim announces 2007 third quarter results
11. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 08, 2016 , ... Launching of the ... Instance Manager architecture, meeting the needs of multichannel growth and doubling the ... auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative flexibility ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, N.Y., ... for adherence to the highest standards of trauma, maternity, cancer and chronic obstructive ... president and CEO, Dr. Daniel Messina. , Among the recognitions, the American College ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... the Affordable Care Act. Dr. Botelho advocates for the mass media launching of ... gives people ongoing opportunities to share their unfortunate experiences; such a movement can ...
(Date:12/8/2016)... AR (PRWEB) , ... December 08, 2016 , ... ... insurance and financial planning services from offices headquartered in Little Rock, has initiated ... Pantry. , According to the National Foundation to End Senior Hunger, Arkansas ranks ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016 CANTEL MEDICAL CORP. (NYSE: CMD ... $0.45 per diluted share, on a 22.1% increase in sales ... 31, 2016. This compares with net income of $14,254,000, or ... first quarter ended October 31, 2015. Non-GAAP ... 31, 2016 to $21,323,000, or $0.51 per diluted share, compared ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... with cutting edge next-generation sequencing and bioinformatics expertise; AITbiotech Pte ... the Genome Institute of Singapore (GIS) ... joint venture between Novogene and AITbiotech – will establish a ... Singapore .   The new centre will ...
(Date:12/7/2016)... --  IQuity, Inc., a specialty diagnostic technology ... has been appointed to its Board of ... experience as CEO, COO, and Board Director for ... the molecular, clinical diagnostic, and medical device industries. ... within the pharmaceutical industry. His operational and commercial ...
Breaking Medicine Technology: